Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$202M Sell
1,707,194
-100,254
-6% -$11.6M 2.17% 19
2026
Q1
$216M Sell
1,807,448
-73,742
-4% -$9.67M 2.45% 19
2025
Q4
$256M Sell
1,881,190
-51,944
-3% -$7.47M 2.57% 17
2025
Q3
$285M Sell
1,933,134
-67,365
-3% -$9.34M 2.88% 15
2025
Q2
$259M Buy
2,000,499
+94,228
+5% +$11.4M 2.68% 17
2025
Q1
$228M Buy
1,906,271
+64,656
+4% +$8.01M 2.7% 17
2024
Q4
$214M Sell
1,841,615
-54,551
-3% -$6.9M 2.56% 16
2024
Q3
$256M Buy
1,896,166
+19,548
+1% +$2.62M 2.94% 14
2024
Q2
$255M Buy
1,876,618
+36,013
+2% +$4.9M 3.17% 15
2024
Q1
$238M Sell
1,840,605
-31,983
-2% -$3.86M 3.2% 15
2023
Q4
$214M Sell
1,872,588
-12,029
-0.6% -$1.2M 3.23% 15
2023
Q3
$172M Buy
1,884,617
+70,729
+4% +$7.29M 2.91% 14
2023
Q2
$204M Buy
1,813,888
+42,706
+2% +$4.52M 3.4% 14
2023
Q1
$185M Buy
1,771,182
+446,712
+34% +$46.7M 3.36% 15
2022
Q4
$146M Buy
1,324,470
+32,133
+2% +$3.37M 2.94% 15
2022
Q3
$113M Sell
1,292,337
-5,868
-0.5% -$533K 2.64% 15
2022
Q2
$101M Buy
1,298,205
+76,415
+6% +$6.31M 2.19% 19
2022
Q1
$104M Buy
1,221,790
+81,385
+7% +$7.8M 2% 18
2021
Q4
$137M Buy
1,140,405
+1,126,414
+8,051% +$140M 2.57% 17
2021
Q3
$1.73M Sell
13,991
-5,336
-28% -$687K 0.04% 25
2021
Q2
$2.32M Sell
19,327
-127
-0.7% -$14.5K 0.06% 23
2021
Q1
$2.05M Buy
19,454
+13,147
+208% +$1.33M 0.07% 24
2020
Q4
$641K Sell
6,307
-12,378
-66% -$1.16M 0.03% 24
2020
Q3
$1.57M Sell
18,685
-13
-0.1% -$1.01K 0.09% 24
2020
Q2
$1.22M Buy
18,698
+916
+5% +$60.5K 0.11% 23
2020
Q1
$1.16M Sell
17,782
-1,060
-6% -$83.5K 0.15% 23
2019
Q4
$1.48M Buy
+18,842
New +$1.47M 0.2% 24

Other funds holding XYL

Mirova US's XYL Position: Q2 2026 in Review

Mirova US reduced its Xylem (XYL) stake by 5.5% in Q2 2026, selling an estimated $11.6M and leaving 1,707,194 shares worth $202M. The position accounts for 2.17% of the portfolio, ranked #19.

Mirova US first reported a position in XYL in Q4 2019 and has held it in 27 quarters since. The position peaked at $285M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Mirova US held 1,707,194 shares of Xylem worth $202M as of Q2 2026.
  • Mirova US sold 100,254 Xylem shares in Q2 2026, an estimated $11.6M.
  • Xylem made up 2.17% of Mirova US's portfolio in Q2 2026, its #19 holding.
  • Mirova US first reported a position in Xylem in Q4 2019 and has held it in 27 quarters since.
  • Mirova US's Xylem position peaked at $285M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Mirova US's 13F filing for Q2 2026, filed 14 Aug 2026.